Suzetrigine mechanism for pain relief (WP5558)
Homo sapiens
Suzetrigine (trade name Journavx) is an oral medication used to manage moderate to severe acute pain. It is a non-opioid, small-molecule analgesic that functions by selectively inhibiting Nav1.8-dependent pain signaling pathways in the peripheral nervous system. Unlike opioids, suzetrigine is non-addictive. Inspired by Figure 2 in Cho et al. (2025).
Authors
Eric WeitzActivity
Discuss this pathway
Check for ongoing discussions or start your own.
Cited In
Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.
Organisms
Homo sapiensCommunities
Annotations
Cell Type Ontology
peripheral sensory neuron sensory neuron of dorsal root ganglion pain receptor cellPathway Ontology
drug pathwayLabel | Type | Compact URI | Comment |
---|---|---|---|
Na+ | Metabolite | chebi:29101 | |
Suzetrigine | Metabolite | drugbank:DB18927 | |
SCN10A | GeneProduct | ensembl:ENSG00000185313 |